NCT02198755Unknown不适用
Sensitivity, Specificity and Predictive Value of High Resolution (B-Mode) Ultrasonography (HRUS) for the Detection of Osteomyelitis in Chronic Wound Patients
Calvary Hospital, Bronx, NY2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年12月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Percent sensitivity and specificity of HRUS as compared to MRI and bone biopsy
研究概览
简要总结
The purpose of this study is to establish the sensitivity of HRUS as compared to MRI for the diagnosis of osteomyelitis in chronic wound patients; and to determine the specificity of HRUS as compared to pathologic and microbiologic studies of bone biopsy tissues.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Diagnostic
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient may be of any race and between 18-85 years of age.
- •Patient has a current diagnosis of a chronic ulcer with suspected osteomyelitis.
- •Patient's ulcer may be due to any etiology including but not limited to diabetes, trauma, neuropathic, pressure, venous, arterial, and inflammatory.
- •Patient's ulcer may extend through the dermis and into subcutaneous tissue (granulation tissue may be present), and may include exposure of muscle, tendon, bone, or joint capsule.
- •Patient's ulcer is suspected of causing a bone infection.
- •Patient's ulcer may be of any size.
- •Patient's wound may present with non-viable tissue.
- •Patient circulation to the wound should be evaluated and treated using normal protocol.
- •Patient's diabetes is under control as determined by the Investigator. Patients must have an HbA1c value less than 13.0%. Those patients whose glucose level is not deemed to be in control should be referred to their primary physician for treatment of the hyperglycemia.
- •Patient and caregiver are willing to participate in the clinical study and comply with the follow-up regimen.
- •Patient or his/her legal representative has read and signed the Institutional Review Board (IRB) approved Informed Consent form before treatment.
- •If patient is capable of childbirth, she is using medically accepted means of birth control, and she tests negative on a serum pregnancy test.
- •Active localized acute wound infection or cellulitis: Subject may be considered for study enrollment after the signs and symptoms of acute infection have resolved.
排除标准
- •Subject has a condition where an MRI is contraindicated
- •Metallic fragments, clips or devices in the brain, eye, spinal canal, etc.: (Plain radiography is sufficient for screening
- •Magnetically activated implanted devices:
- •Cardiac pacemakers, insulin pumps, neuro¬stim¬u¬lators, cochlear implants, etc. may be de-programmed.
- •Non-graphite spinal cord tongs: Graphite tongs are compatible.
- •Thermodilution Swan-Ganz catheter: Local heating can result. If unenhanced MRI is likely to provide sufficient information, gadolinium should not be administered to these patients. If, after review of clinical indications, gadolinium enhancement is judged to be important for diagnosis, the lowest effective dose of contrast agent should be used.
- •In subjects where gadolinium enhancement MRI is planned then the following exclusion criteria apply:
- •Subject is allergic to contrast materials or cannot tolerate gadolinium
- •Subject is at risk of nephrogenic systemic fibrosis (NSF) or has severe renal failure (as determined by the investigator)
- •Patient must not be pregnant.
- •Patient has any condition(s) that seriously compromises the patient's ability to complete this study.
- •Patient with recent surgical debridement of the bone in and around the ulcer site.
研究组 & 干预措施
High Resolution Ultrasound
Active Comparator
High Resolution Ultrasonography (HRUS) with a Hitachi-Aloka Noblus Scanner
干预措施: Hitachi-Aloka Noblus ultrasound scanner (Device)
Magnetic Resonance Imaging (MRI)
Active Comparator
Magnetic Resonance Imaging (MRI)
干预措施: Magnetic Resonance Imaging (MRI) (Device)
结局指标
主要结局
Percent sensitivity and specificity of HRUS as compared to MRI and bone biopsy
时间窗: at 3 weeks
次要结局
未报告次要终点
研究者
Oscar M. Alvarez, PhD
Director, Center for Curative and Palliative Wound Care
Calvary Hospital, Bronx, NY
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Magnetic Resonance Imaging in the Evaluation of Liver FibrosisLiver FibrosisNCT01572064University of Nottingham134
已完成
不适用
Detection of Renal Malignancy of Complicated Renal CystsKidney NeoplasmCystsCarcinoma, Renal CellNCT01087060Seoul National University Hospital269
已完成
1 期
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal MetastasesBone MetastasisNCT01309048Philips Healthcare10
招募中
不适用
Magnetic Resonance Imaging and Biomarkers for Muscular DystrophyBecker Muscular DystrophyDuchenne Muscular DystrophyNCT01484678University of Florida550
撤回
4 期
ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) PatientsNormal Pressure HydrocephalusNCT00793416NeuroDx Development